Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Biobeat
Biobeat Overview
Biobeat provides wearable remote patient monitoring solutions for the healthcare continuum. The companys AI-driven remote patient monitoring platform includes a disposable short-term chest monitor and a long-term wrist monitor. Both monitors utilize a PPG sensor to continuously provide accurate readings of 13 health parameters, including cuffless blood pressure, pulse rate, respiratory rate, blood oxygen saturation, temperature, stroke volume, cardiac output, one-lead ECG (chest monitor only), and more.
Leveraging its automatic, continuous, and noninvasive RPM AI platform, Biobeat utilizes its vital sign database to identify early deterioration of patients via its proprietary big data and health-AI tools. Aggregated patient health data is viewed by medical staff via Biobeats secure HIPPA and GDPR compliant cloud-based patient management platform.
Biobeats platform utilizes an automated real-time early warning score system that incorporates advanced AI-based algorithms to provide alerts on patient health status and potential deterioration. These capabilities allow Biobeat to support medical teams with tailored patient care, such as adjustment of therapeutics and early prevention of specific disease exacerbations.
BioBeats wearable devices are FDA cleared and CE marked.